Often referred to as “type 3 diabetes” [9], AD has been linked to impaired insulin signaling, which disrupts glucose metabolism, neuronal survival, and synaptic plasticity, thereby exacerbating neurodegeneration [6,9,10,11]. This evidence concerns the gene INS and Alzheimer disease.